Neuromonitorings and strategy for acute treatment in neurological emergencies

Abstract

The use of neuromonitoring is spreading in the field of neurological emergency treatment, i.e., treatment for traumatic brain injury (TBI), stroke, and post cardiac arrest syndrome (PCAS) patients. For example, continuous EEG (cEEG) and regional brain tissue oxygen saturation (rSO2) are now widely used in PCAS patients for predicting neurological outcome and assuring quality of resuscitation. Several biomarkers such as ubiquitin carboxyl hydrolase-L1 (UCH-L1), and glial fibrillary acidic protein (GFAP) are also now widely accepted as neuronal and glial cell marker in brain and spinal cord injury (SCI). In this review, we first mention the differentiation of neuromonitoring, generally divided as regional and global monitors. We then show our clinical data and research data for several neuromonitoring cases in PCAS and SCI patients. We hope this review will help further your understanding and help inform you in the decision making process in neurocritical care.